Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-013927
Filing Date
2023-04-28
Accepted
2023-04-27 20:22:17
Documents
3
Period of Report
2023-04-27

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 496972
2 def_001.jpg GRAPHIC 176175
3 def_002.jpg GRAPHIC 167741
  Complete submission text file 0001493152-23-013927.txt   971897
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39318 | Film No.: 23859527
SIC: 2834 Pharmaceutical Preparations